Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Friday, September 11, 2026

Snapshot: Sep 11, 2026 · 6:00 PM 100 stocks analyzed

Strong Down Day

Fri, Sep 11, 2026 Broad Selloff High

Broad selloff hammers S&P 500 and Russell 2000, with healthcare leading losers and high single-stock dispersion as a handful of SPAC deals and micro-cap earnings surprises surge…

60% S&P 500 fell 1.17%, Dow dropped 2.07%, and Russell 2000 plunged 2.17%, marking a clear broad selloff with the most damage in small caps and blue chips; VIX nudged up 3.5% but fear remained contained, suggesting profit-taking rather than panic.
25% Healthcare sector dominated the losers list at 36% of names, while a handful of tickers rallied on specific catalysts—CHPGR +89% on SPAC deal announcement, FEIM +43% on record Q1 revenue and earnings beat, CRBP +24% on obesity drug trial data presentation—creating high single-stock dispersion as newsworthy outliers fought a down market.
15% Reverse splits and capital raises triggered sharp declines in distressed names (OPTT -32.4%, HUBC -16%, PMTS -16% on secondary offering), while a 4-day losing streak in LHSW and five debutants hitting losers after long absences signaled fresh weakness spreading across the micro-cap space.

Healthcare drove 36% of losers 5 names returned after long absences LHSW · 4-day losers streak BURUD · 3-day gainers streak AENT — first appearance PMTS — first appearance

Market Regime

Fri, Sep 11, 2026 Neutral conf: medium macro · prototype

Neutral −100 … +100 · + tailwind / − headwind

VIX15.8 p33 Drawdown-1.8% Held1d · nascent SinceSep 11

Top drivers: VIX percentile ▲ Small-cap leadership ▼ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Fri, Sep 11, 2026 13

S&P 500

7,656.98

−90.73

-1.17%

Dow Jones

52,573.29

−1,112.82

-2.07%

NASDAQ Composite

26,333.04

−251.03

-0.94%

NASDAQ 100

29,368.44

−113.88

-0.39%

DJ US Total Market

75,629.20

−960.77

-1.25%

Russell 1000

4,167.26

−52.83

-1.25%

S&P MidCap 400

3,714.14

−65.71

-1.74%

Russell 2000

2,903.94

−64.33

-2.17%

Russell 2500

1,242.98

+8.51

+0.69%

Russell 3000

4,345.43

−56.76

-1.29%

Nasdaq Financial-100

7,594.11

+22.58

+0.30%

NIFTY 50

23,398.10

−381.05

-1.60%

VIX

15.84

+0.54

+3.53%

Biggest Gainers

Fri, Sep 11, 2026 50

CHPGR

ChampionsGate Acquisition Corporation Rights

$0.19+$0.09

+89.0%

NASDAQ

ChampionsGate Acquisition Corp announced a definitive business combination agreement with Futuremain Co., Ltd. on September 11, triggering an 89% rally in the SPAC rights offering as investors repriced the likelihood of deal completion.

ChampionsGate is a Special Purpose Acquisition Company (SPAC), and CHPGR represents the rights issued to existing shareholders. The announcement of a definitive merger agreement with Futuremain, a South Korea-based engineering and IT company, is a major catalyst for SPAC securities. Before this announcement, the rights had uncertain value tied only to the probability and terms of a future business combination. The definitive agreement eliminates deal uncertainty and establishes concrete terms, typically triggering sharp appreciation in SPAC equity and rights as arbitrage spreads compress and investors price in imminent recapitalization. Rights holders gain exposure to the post-merger entity with favorable economics, explaining the outsized one-day gain. The exact magnitude depends on deal terms, valuation, and market sentiment toward the target company, but the directional move is entirely consistent with SPAC merger announcement patterns.

TRUG

TruGolf, Inc.Consumer Cyclical

$0.65+$0.28

+75.7%

NASDAQ · Mkt cap $1.2 M

No headlines were found in the last 48 hours to explain TRUG's 75.71% gain, so the precise catalyst remains unknown; the jump may reflect technical trading, delayed news dissemination, or sector-specific momentum.

TruGolf is a micro-cap stock trading at $0.65 with a substantial single-day gain of over 75 percent, yet no news articles from the past two days appear in the available feed. This creates a significant information gap. For stocks at this price level and market capitalization, catalysts typically include small-cap earnings surprises, insider buying announcements, reverse merger activity, options-driven technical moves, or sector rotation into golf or sports-tech equities. The absence of headlines does not rule out a material event; news may not yet have propagated to major feeds, or the move could reflect algorithmic trading, short-covering, or retail interest driven by social platforms rather than traditional news channels. Without additional context about TRUG's recent operations, insider activity, or technical setup, pinpointing the driver requires inference rather than fact.

ROC

ROC Energy Acquisition Corp.

$4.25+$1.65

+63.5%

NASDAQ · Mkt cap $83 M

No news headlines were found in the last 48 hours, so the 63.46% jump cannot be tied to any reported event. The move is likely driven by technical factors, untracked rumors, or delayed market reaction to an earlier announcement.

ROC Energy Acquisition Corp. is a SPAC (special purpose acquisition company), which means it is inherently volatile and typically illiquid until merger announcement or close. A 63% single-day move on no visible news is characteristic of SPAC behavior, where thin trading volume and retail momentum can amplify intraday swings. Possible drivers for a move of this magnitude without headline coverage include: (1) a merger agreement or LOI (letter of intent) that has been filed but not yet picked up by major financial news aggregators, (2) insider or rumor-driven retail buying ahead of an expected announcement, or (3) a technical squeeze in a thinly traded float. Without access to SEC filings or real-time corporate announcements beyond the Yahoo Finance RSS feed, we cannot confirm which scenario applies.

CETU

Cetus Capital Acquisition Corp. - Class A Common Stock

$7.75+$2.65

+52.0%

DMAQ

Deep Medicine Acquisition Corp.

$0.65+$0.21

+47.8%

GTBP

GT Biopharma Inc.Healthcare

$8.50+$2.61

+44.3%

NASDAQ · Mkt cap $11 M

GT Biopharma announced a live company presentation on its TriKE® cancer treatment platform on September 11, 2026, likely catalyzing the 44.31% intraday surge as investors reacted positively to the development-stage immunotherapy opportunity.

The single headline provided is a corporate event announcement—GT Biopharma scheduled a live presentation to discuss its TriKE® platform technology for cancer treatment on the same day as the stock's surge. While the headline does not contain specific clinical trial results, regulatory approvals, or partnership news, the timing of a public company presentation often signals readiness to communicate progress or milestones to investors and the market. For a clinical-stage immuno-oncology company, investor presentations can serve as catalysts if they highlight advancement in development, preclinical data, or strategic partnerships. The magnitude of the gain (44.31%) suggests market participants viewed the presentation or anticipated announcements favorably, though the headline text itself is truncated and does not reveal the actual content discussed during the event. No competing news or contradictory information is present to explain the move otherwise.

FEIM

Frequency Electronics IncTechnology

$88.56+$26.62

+43.0%

NASDAQ · Mkt cap $669 M

Frequency Electronics soared 43% after reporting record Q1 fiscal 2027 revenue of $23.5 million, up 70% year-over-year, with record $129 million backlog and earnings beat, driven by strong satellite and defense demand.

The headlines establish a clear earnings-driven catalyst. FEIM reported fiscal Q1 2027 results that exceeded expectations across multiple dimensions: revenue rose 70% year-over-year to $23.5 million, net income was $0.41 per share (implying strong profitability), and the funded backlog hit a record $129 million, up 82% year-over-year. The company cited growth in satellite and U.S. government and defense programs as drivers. Premarket trading showed a 30.5% jump before the official open, and the stock continued climbing throughout the day to finish up 43%. The space and defense exposure, combined with visible revenue acceleration and record backlog, provides investors concrete evidence of both current performance and future revenue visibility, which explains the magnitude of the rally.

MKDW

MKDWELL Tech Inc. Ordinary Share

$7.62+$2.08

+42.4%

FSHPR

Flag Ship Acquisition Corporation

$0.10+$0.03

+38.1%

NASDAQ

No news headlines were found in the last 48 hours, so the 38% gain in FSHPR cannot be attributed to a specific announced event. The move is likely driven by technical factors, short interest, or undetected market sentiment shifts.

Flag Ship Acquisition Corporation is a blank-check company (SPAC), a security class prone to large intraday swings on minimal news flow. The complete absence of headlines in the 48-hour window prior to this 38% jump suggests the catalyst was either not yet widely reported by major news aggregators, originated from social media or message boards, or was technical in nature. SPACs often experience sharp moves tied to rumors of pending mergers, insider activity, or shifts in options positioning. The stock's extremely low price of $0.10 also makes it susceptible to retail attention and round-lot accumulation. Without any concrete news, the most likely explanations are either a delayed or unreported corporate development, short-covering pressure, or a technical reversal off a recent low.

VSME

VS Media Holdings Limited - Class A Ordinary SharesCommunication Services

$1.07+$0.33

+36.3%

NASDAQ · Mkt cap $3.2 M

No news was reported in the last 48 hours, so the 36% gain on VSME likely reflects a delayed market reaction to an earlier announcement, a technical or sentiment shift, or an undisclosed catalyst not yet covered by major outlets.

The absence of any headlines in the last 48 hours is notable given the stock's strong 36% single-day gain, placing it among the top 10 gainers on NASDAQ. This disconnect suggests either that the news catalyst predates the headline search window, that the move is driven by technical factors such as short covering or options expiration mechanics, or that material information has circulated through channels not yet reflected in mainstream financial news feeds. For a lower-priced stock like VSME trading at $1.07, typical catalysts include insider buying, restructuring announcements, debt modification, or changes in shareholder composition. Without access to the underlying news, the most probable categories are a delayed reaction to recent corporate action, retail investor momentum, or algorithmic trading response to technical levels, but these remain speculative.

AFJKR

Aimei Health Technology Co., Ltd Right

$0.15+$0.04

+36.2%

NCT

Intercont (Cayman) Limited Ordinary sharesIndustrials

$0.30+$0.10

+33.9%

NASDAQ · Mkt cap $38 M

NCT surged 33.88% following a September 10 official shareholder statement emphasizing long-term commitment, compliance and transparency, likely signaling resolution of prior governance or operational concerns.

The single headline available is an official statement from NCT reaffirming commitment to shareholders on compliance and transparency. While the full text is truncated, such statements are typically issued when a company seeks to rebuild confidence after negative events, governance disputes, or regulatory scrutiny. The timing of the statement on September 10 followed by a 34% jump the next trading day suggests market participants interpreted the message as reassurance or resolution. However, without the complete statement details or context on what prompted it, the specific catalyst remains partially obscured. The stock's penny-stock price level and ranking as the 12th biggest gainer suggest it may trade with high volatility and thin liquidity, amplifying percentage moves. The statement alone is sufficient to explain the direction but not the full magnitude without additional context.

FTFT

Future FinTech Group IncTechnology

$2.85+$0.69

+32.7%

NASDAQ · Mkt cap $1.8 M

No news headlines appeared in the last 48 hours, so the 32.70% gain likely stems from technical buying, short covering, or an undisclosed catalyst not yet reflected in major financial news feeds.

Future FinTech is a small-cap stock trading on NASDAQ with a market structure that can amplify intraday volatility and attract retail or momentum-driven trading. The absence of any published headlines in the provided timeframe means the driver of today's jump is not immediately attributable to earnings, guidance, partnership announcements, or regulatory actions. For stocks in this category, large single-day moves often reflect short-covering rallies, technical breakout buying, options-related positioning, or sector-wide momentum in fintech. It is also possible that a news event occurred but has not yet propagated to Yahoo Finance RSS feeds, or that buying was driven by social media discussion or insider accumulation. Without corroborating reporting, the precise catalyst remains unknown.

SWRD

Stewards, Inc

$2.93+$0.72

+32.3%

BURUD

NUBURU INC

$2.55+$0.61

+31.4%

BCAB

BioAtla, Inc.

$1.55+$0.37

+31.4%

SXTC

China SXT Pharmaceuticals IncHealthcare

$2.52+$0.59

+30.6%

NASDAQ · Mkt cap $2.4 M

No news headlines were found in the last 48 hours to explain SXTC's 30.57% gain, so the driver remains unclear from available sources. The jump is likely due to technical trading, a delayed announcement, or market rumor.

Yahoo Finance returned zero headlines for SXTC in the past two days despite the stock being the 17th largest gainer on the day. This absence of news coverage is notable, especially for a NASDAQ-listed pharmaceutical stock posting a 30% move. Biotech and pharma stocks can spike sharply on catalysts like clinical trial results, regulatory approvals, financing announcements, or insider buying. Without any reported news, the most plausible explanations are either a real event that has not yet been picked up by major financial media, a technical or short-squeeze-driven rally, or a rumor circulating in retail trading channels that precedes formal disclosure.

COLA

Columbus Acquisition Corp Ordinary Shares

$10.60+$2.31

+27.8%

SOAR

Volato Group, Inc.Industrials

$0.19+$0.05

+27.1%

NYSE · Mkt cap $7.8 M

No news headlines were reported in the last 48 hours for Volato Group (SOAR), so the 27.10% intraday gain cannot be directly attributed to a disclosed catalyst. The move likely reflects either a technical or sentiment-driven bounce in a micro-cap stock.

The absence of any recent news headlines creates a clear gap between the price action and publicly announced catalysts. Volato Group is a micro-cap aviation services company, and stocks in this category often exhibit outsized volatility on low trading volume, technical rebounds, short-covering, or unconfirmed rumors that may circulate on forums or social media before appearing in mainstream financial news feeds. A 27% jump on no disclosed news is typical behavior for thinly traded equities. Without evidence of an earnings release, contract win, financing, or operational update, the most plausible explanations fall into technical trading (oversold bounce), sentiment shifts among retail investors, or a delayed news pickup that hasn't yet surfaced in the Yahoo Finance RSS feed used here. The rank as 19 biggest gainer suggests real volume participation, but that alone does not identify the source catalyst.

AMPGZ

Amplitech Group, Inc. Series B Right

$0.22+$0.05

+26.9%

NASDAQ

No news headlines were found in the last 48 hours, so the 26.94% gain in AMPGZ (a Series B rights offering security) likely reflects either technical activity in a low-liquidity instrument, a delayed market reaction to an earlier announcement, or broader market movement in the parent company Ampl…

The absence of recent news headlines means we cannot point to a specific catalyst such as earnings, product announcements, or corporate actions. AMPGZ is a Series B right, which is a derivative security tied to the parent company's stock. Rights offerings typically experience volatility when the underlying stock moves, when redemption or exercise deadlines approach, or when liquidity conditions change. Given the thin trading likely in this instrument and its +26.94% single-day gain, the move could reflect: (1) a rally in Amplitech Group's common stock that cascaded into this right, (2) technical rebalancing or short covering in a low-float security, or (3) a delayed market response to news that did not yet surface in the Yahoo Finance RSS feed used here. Without contemporaneous headlines, we cannot isolate the true driver.

CRBP

Corbus Pharmaceuticals Holdings IncHealthcare

$8.13+$1.99

+24.3%

NASDAQ · Mkt cap $195 M

Corbus Pharmaceuticals jumped 24.27% on news that it will present topline data from its CANYON-1 clinical trial for the obesity drug CRB-913 at a conference call on September 14, 2026, generating anticipation ahead of the data release.

The headline announces that Corbus will host a conference call on Monday, September 14 to discuss topline results from the CANYON-1 trial of CRB-913, its clinical-stage obesity therapeutic. The stock's sharp gain on September 11 (the announcement day) likely reflects investor optimism about an upcoming data readout in a high-interest therapeutic area. Obesity drugs have been a strong market focus following the success of GLP-1 agonists. The market is pricing in positive expectations ahead of the actual data presentation. However, the headline does not disclose the actual trial results—only that results will be shared in three days. The 24% move is based on anticipation rather than confirmed efficacy or safety data, making this a momentum-driven rally ahead of a binary event.

GLE

Global Engine Group Holding Limited Ordinary SharesTechnology

$0.57+$0.10

+22.8%

NASDAQ · Mkt cap $6.8 M

No headlines were found in the last 48 hours to explain the 22.80% jump in GLE stock, so the cause remains unclear without additional context on news or corporate events.

The absence of any news headlines in the 48-hour window preceding this significant gain makes it difficult to identify a specific catalyst. Global Engine Group is a relatively small-cap stock trading at $0.57, and such stocks are often sensitive to technical factors, thinly-traded volume spikes, delayed press releases not yet picked up by major feeds, insider activity disclosures, or sector-wide developments in industrial or energy sectors. Without concrete headlines, the most likely categories of cause would be either a technical rebound after prior weakness, a low-liquidity gap move on modest volume, or an announced event that has not yet propagated through RSS feeds at the time of this snapshot. Retail interest in penny stocks can also drive rapid moves on sentiment shifts unrelated to fundamental news.

LKSPR

Lake Superior Acquisition Corp. Rights - For Shares

$1.41+$0.26

+22.6%

NASDAQ

No news headlines were reported in the last 48 hours, so the 22.61% gain likely reflects either a technical bounce in a thinly traded rights offering, a delayed market reaction to an untracked announcement, or speculative activity common to SPAC-related securities.

Lake Superior Acquisition Corp. Rights are a specialized SPAC-related security with limited liquidity and high volatility characteristics. The absence of any news in the provided headlines means we cannot point to a specific catalyst like a merger announcement, deal progress update, or corporate action. However, rights offerings on blank-check companies are inherently sensitive to sentiment shifts regarding the underlying SPAC's acquisition prospects. Possible explanations include a late-breaking announcement not yet captured in the news feed, technical oversold conditions prompting a mean-reversion bounce, or market speculation about pending SPAC developments. Rights securities can experience outsized percentage moves on relatively small absolute volume, so a 22.61% jump does not necessarily indicate major news. Without contemporaneous headlines or company filings, attribution remains speculative.

COPR.WT

$1.83+$0.33

+22.0%

TRAD.UN

$12.40+$2.09

+20.3%

OIO

OIO GroupIndustrials

$1.97+$0.33

+20.1%

NASDAQ · Mkt cap $679 M

No news headlines were published in the last 48 hours, so the 20% gain likely reflects either a delayed market reaction to an untracked announcement, technical trading, or a rumor not yet picked up by major news wires.

OIO Group has no identifiable news catalyst in the Yahoo Finance feed for the past two days, despite a substantial single-day gain of over 20%, placing it among the top 26 daily gainers. For a micro-cap or thinly traded NASDAQ stock like OIO, a move of this magnitude without visible news typically falls into one of two categories: first, a delayed reaction to a press release or corporate announcement that has not yet been indexed by broad financial news aggregators; second, technical or sentiment-driven trading, which is common in lower-liquidity equities where small order flows can move the price sharply. Without access to the company's investor relations page or real-time social media mentions, we cannot determine which scenario applies here.

ARCLR

ARC Group Acquisition I Corp Right

$0.18+$0.03

+20.1%

ATEC

Alphatec Holdings IncHealthcare

$10.59+$1.75

+19.8%

NASDAQ · Mkt cap $1.4 B

No news headlines were available in the last 48 hours to explain ATEC's 19.80% jump, so the catalyst remains unclear without additional information about company announcements, sector moves, or market-wide events on that date.

Alphatec Holdings (ATEC) jumped nearly 20% on September 11, 2026, but no headlines appear in the provided Yahoo Finance RSS feed from the prior 48 hours. This absence of news does not rule out an identifiable cause, which could include an after-hours announcement, earnings release, clinical trial result update, regulatory filing, or analyst upgrade that may not have been indexed by Yahoo Finance at the time of the snapshot. For a spinal implant and surgical technology company like ATEC, typical catalysts include FDA clearances, hospital contract wins, or guidance revisions. Alternatively, sector momentum in medtech, options-related positioning, or short-covering could contribute. Without corroborating news or structural context, the specific driver cannot be determined from this data alone.

NCRA

Nocera Inc.Consumer Defensive

$2.22+$0.36

+19.4%

NASDAQ · Mkt cap $3.2 M

No news headlines were found in the last 48 hours, so the 19.35% gain on NCRA likely stems from technical trading, a delayed press release not yet indexed, or market rumor rather than a confirmed catalyst.

The absence of any news in the provided Yahoo Finance RSS feed over the last 48 hours makes it difficult to pinpoint a specific catalyst for the 19.35% jump. Nocera Inc. is a small-cap biotech or specialty materials company, which historically can experience sharp single-day moves on relatively light volume driven by technical factors, short covering, or undisclosed developments. Given that NCRA ranked 29th among daily gainers, it is plausible that a material announcement occurred but has not yet propagated through major news aggregators, or that the move reflects sector-wide bullish momentum or a liquidity-driven event. Without corroborating headlines or public disclosures, attributing the move to a specific business catalyst would be speculation.

AIXC

Aixcrypto Holdings IncTechnology

$0.88+$0.14

+18.9%

CCG

Cheche Group Inc. - Class A Ordinary SharesCommunication Services

$15.96+$2.51

+18.7%

NASDAQ · Mkt cap $34 M

No news headlines appeared in the last 48 hours, so the 18.68% gain cannot be directly attributed to a specific corporate announcement or market event based on available information.

The absence of recent news headlines makes it difficult to pinpoint the exact catalyst for CCG's +18.68% jump on September 11, 2026. The stock ranked as the 31st biggest gainer of the day, suggesting it moved alongside broader market momentum or sector-specific tailwinds rather than in response to company-specific news. Without disclosed headlines, the move could stem from several possible sources: a delayed market reaction to an earlier announcement not yet captured in the RSS feed, technical factors such as short covering or options-related hedging, sector rotation favoring stocks in CCG's industry, or retail trading interest. Without access to the underlying business fundamentals, recent earnings, or company guidance changes, any explanation remains speculative.

PSIG

PS International Group Ltd. Ordinary SharesIndustrials

$2.69+$0.42

+18.5%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours to explain PSIG's 18.47% gain, so the cause remains unclear without additional context or intraday information.

PSIG jumped 18.47% on September 11, 2026, ranking 32 among daily gainers, but no headlines appear in the Yahoo Finance RSS feed for the prior 48 hours that would account for this move. This absence of news does not rule out a catalyst entirely—the move could reflect delayed market reaction to an announcement, intraday trading activity, technical factors such as short covering or options expiry effects, or information that has not yet been indexed by the RSS feed. For a microcap or lower-liquidity stock like PSIG, single-day swings of this magnitude can also occur on relatively light volume or algorithmic trading. Without access to intraday news wires, SEC filings, press releases, or order-flow data, attribution remains speculative.

FGL

Founder Group Limited Ordinary SharesIndustrials

$5.44+$0.91

+18.2%

NASDAQ · Mkt cap $475 K

No news headlines were found in the last 48 hours, so the 18.24% gain likely stems from technical factors, delayed news coverage, or market rumors rather than a newly announced catalyst.

FGL surged 18.24% to rank 33rd among daily gainers, yet no recent news articles appear in the Yahoo Finance RSS feed covering the stock in the prior 48 hours. This disconnect suggests either that a catalyst existed but was not picked up by the headline service, or that the move was driven by technical trading activity such as short covering, options-related hedging, or retail momentum. Small-cap stocks like FGL are often sensitive to liquidity shifts and positioning changes that do not require fundamental news. Without visibility into insider transactions, analyst upgrades, sector momentum, or delayed earnings announcements, the specific driver remains unclear, though the most common explanations for large single-day moves absent same-day headlines are technical rebalancing, squeeze activity, or news that simply has not yet been indexed by major financial news aggregators.

RDIB

Reading International IncCommunication Services

$17.01+$2.55

+17.6%

NASDAQ · Mkt cap $204 M

No news headlines were found in the last 48 hours for RDIB, so the 17.63% gain likely reflects either delayed coverage of an earlier announcement, technical buying, or market rumors that have not yet been reported through mainstream channels.

Reading International Inc, a smaller-cap cinema and entertainment operator, experienced a significant single-day rally with no corresponding news coverage in the provided Yahoo Finance RSS feed from the last 48 hours. This disconnect between a top-35 daily gainer and zero recent headlines suggests several possibilities. First, the catalyst may be older news that the market is only now pricing in, or coverage may exist outside the RSS feed timeframe. Second, stocks in the entertainment and cinema sector can be sensitive to short covering, technical breakouts from oversold levels, or sector-wide momentum shifts tied to box office performance or theatrical release calendars. Third, a rumor or institutional accumulation could be driving the move ahead of any formal announcement. Without named catalysts, attributing the move to any specific fundamental event would be speculation.

DSX.WT

Diana Shipping Inc. WT

$1.08+$0.16

+17.4%

PMI

Picard Medical, Inc.Healthcare

$5.25+$0.79

+17.3%

NYSE · Mkt cap $6.8 M

No news headlines were found in the last 48 hours, so the 17.32% jump cannot be attributed to a specific announced event. The move likely reflects a technical bounce, delayed news pickup, or market rumors not yet captured in major financial feeds.

PMI showed no recent headline coverage despite a substantial single-day gain of 17.32%, placing it among the top 36 gainers on the NYSE. This disconnect between price action and visible news suggests the catalyst either has not yet been widely reported, occurred outside the monitored news window, or stems from technical factors such as short covering or options-related positioning. For a smaller-cap medical device company like Picard Medical, common catalysts might include clinical trial results, regulatory approvals, partnership announcements, or insider transactions, but without corroborating headlines, we cannot confirm any of these. The absence of contemporaneous news coverage is notable and limits confidence in any specific explanation.

VERI

Veritone IncTechnology

$1.03+$0.15

+17.0%

NASDAQ · Mkt cap $97 M

Veritone gained 17% likely on positive investor sentiment from announced demos of new Video Intelligence product at IBC2026 and upcoming investor conference presentation, though no major contract or earnings driver is disclosed.

Two announcements arrived within hours on September 10: the company will showcase new Veritone Video Intelligence at IBC2026 in Amsterdam, positioning it as a transformative tool for media organizations, and CEO Ryan Steelberg will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14. Neither headline discloses a signed contract, earnings beat, or guidance raise. However, for a micro-cap AI software vendor trading below $1.05, product demos and conference visibility can drive material short-term sentiment, particularly if investors view the Video Intelligence suite as a credible monetization pathway. The 17% single-day gain suggests modest existing holder enthusiasm or possible short covering, rather than response to hard fundamental news. The stock's rank as 37th biggest gainer indicates broad retail or technical interest rather than institutional catalyst.

UPC

Universe Pharmaceuticals INCHealthcare

$4.47+$0.65

+17.0%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours to explain the 17.02% gain, so the catalyst remains unclear without additional context or real-time data sources.

Universe Pharmaceuticals experienced a significant one-day jump of 17.02%, placing it among the top 38 gainers on NASDAQ, yet no recent news headlines are available through the Yahoo Finance RSS feed to explain the move. For a smaller-cap pharmaceutical stock, typical catalysts include clinical trial results, regulatory decisions, partnership announcements, or analyst coverage initiation. The absence of captured headlines could mean the news broke outside monitored channels, arrived very recently, or the move was driven by technical factors such as short covering, options-related positioning, or broad sector sentiment shifts. Without concrete information, we cannot determine whether this was fundamental news-driven or purely technical in nature.

USDEW

StablecoinX Inc. Warrants

$1.76+$0.25

+17.0%

CRMT

America's Car-Mart Inc-TXConsumer Cyclical

$1.86+$0.27

+17.0%

NASDAQ · Mkt cap $27 M

After a devastating 41.8% drop on September 9 following missed Q2 revenue and massive losses, CRMT rebounded 16.99% on September 11, likely reflecting either technical oversold bounce-back or selective bargain-hunting despite the company's deteriorating fundamentals.

The headlines establish that America's Car-Mart reported Q2 2026 revenue of $145.8 million, down 57.1% year-over-year, with a non-GAAP loss of $6.65 per share. This triggered the 41.8% collapse on September 9. The September 11 rebound of 16.99% occurs two days later with no new company-specific news provided. The broader macro context includes August PPI data showing 5.4% year-over-year inflation and crude oil above $100 per barrel, both headwinds for consumer retail. The most likely explanations for the bounce are technical oversold conditions after such a severe decline, possible short-covering, or value investors testing bottom support levels despite fundamentals remaining weak. The absence of favorable company news means the bounce contradicts the underlying business deterioration rather than resolving it.

SEGG

Lottery.com, Inc.Consumer Cyclical

$3.63+$0.53

+17.0%

NASDAQ · Mkt cap $8.4 M

No news headlines were found in the last 48 hours, so the 17% gain likely reflects technical trading activity, short covering, or an untracked announcement or rumor in the microcap lottery-gaming space.

Lottery.com is a small-cap NASDAQ stock with minimal mainstream financial coverage, which means material news often fails to appear in major RSS feeds or is distributed through alternative channels. The 17% single-day jump with zero tracked headlines suggests either a delayed or localized news event, momentum trading in a thinly traded name, short-squeeze activity common in microcaps, or technical chart-based buying. Stocks in the lottery and gaming sector can also experience sharp moves on regulatory developments or business partnership announcements that take time to surface in tracked media. Without access to company press releases, social media, or Level 2 trading data, attributing this move to a specific catalyst is not possible.

XHLD

TEN Holdings, Inc. Common StockCommunication Services

$12.49+$1.83

+16.9%

NASDAQ · Mkt cap $92 M

No news headlines were found in the last 48 hours for XHLD, so the 16.93% gain lacks an obvious public catalyst; the move may reflect technical factors, delayed news propagation, or market-wide sentiment shifts.

The absence of recent Yahoo Finance headlines is a significant constraint on analysis. A 16.93% single-day gain for a stock trading under $13 can occur for several reasons that do not always generate immediate news coverage. Possible explanations include a technical or short-squeeze event, insider trading activity, sector rotation or market sentiment favorable to whatever industry Ten Holdings operates in, or delayed disclosure of material information that has not yet propagated to major financial news feeds. Without knowing Ten Holdings' business, recent financial position, short interest, or whether any earnings or guidance changes occurred outside the 48-hour window, the most honest assessment is that this move is not yet grounded in publicly identified news.

AENT

Alliance Entertainment Holding Corporation

$6.50+$0.90

+16.1%

ZIVO

Zivo Bioscience, Inc.Healthcare

$4.15+$0.55

+15.3%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the 15.28% gain likely reflects a technical bounce, delayed market reaction to earlier developments, or micro-cap volatility typical of small biotech stocks.

Zivo Bioscience is a micro-cap biotech company, and the absence of any news in the most recent two-day window does not rule out prior announcements or market events that may have driven the move. Biotech stocks of this scale often exhibit outsized volatility on relatively low trading volume, and a 15% single-day move is not uncommon during market corrections or reversals. The stock could have rebounded from an earlier selloff, responded to sector-wide positive sentiment, or simply experienced a technical rebound at a support level. Without access to headlines prior to the 48-hour window or real-time trading data, it is not possible to pinpoint a specific catalyst. Clinical trial news, partnership announcements, or changes in capital structure are typical drivers for this type of stock, but none are confirmed here.

AQB

AquaBounty Technologies IncConsumer Defensive

$1.22+$0.16

+15.1%

NASDAQ · Mkt cap $6.8 M

No news headlines were found in the last 48 hours, so the 15% gain on AquaBounty Technologies likely reflects a delayed market reaction to an earlier announcement, technical or sentiment-driven trading in a micro-cap biotech stock, or an undetected news event.

AquaBounty Technologies is a small-cap aquaculture biotech firm that can experience outsized price swings on limited volume, and the absence of recent news headlines does not rule out a delayed market reaction to an earlier development or announcement that may not have been immediately picked up by major financial RSS feeds. The 15% single-day jump could also reflect short covering or technical breakout buying in a thinly traded name. Without headlines directly tied to the move—such as FDA approval, partnership announcements, earnings surprises, or guidance updates—we cannot pinpoint a specific catalyst. For biotech and aquaculture plays in this market-cap range, common drivers include regulatory actions, competitive developments, or shifts in investor sentiment toward the sector, but none of these are confirmed here.

NXTT

Next Technology Holding Inc.Technology

$5.30+$0.68

+14.7%

NASDAQ · Mkt cap $9.8 M

No news headlines were found in the last 48 hours, so the 14.72% gain cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, delayed news processing, or undisclosed market factors.

The absence of recent headlines is the primary challenge here. NXTT, a small-cap technology holding company, moved up sharply to rank 46th among daily gainers, but no corresponding news event is documented in the available RSS feed. In such cases, moves in smaller-cap stocks often stem from several possible sources: technical breakouts or chart-driven buying, short squeeze activity if the stock has notable short interest, sector rotation into technology names, or delayed dissemination of news through major financial channels. Without access to earnings releases, SEC filings, press releases issued directly by the company, or trading volume and short interest data, the underlying cause remains speculative. It is also possible that a material announcement was made but has not yet been indexed by Yahoo Finance RSS.

ODD

ODDITY Tech Ltd. - Class A Ordinary SharesConsumer Defensive

$18.32+$2.34

+14.6%

NASDAQ · Mkt cap $738 M

ODD surged 14.64% following Q2 2026 earnings that showed a 25% revenue decline but signaled growth momentum from new ventures and expected sequential improvement, causing investors to look past legacy brand weakness.

The earnings headlines establish that Oddity Tech reported a materially disappointing quarter with IL MAKIAGE revenue under pressure and a 25% overall sales decline. However, the market response was notably positive. The second headline explicitly notes the stock "soared anyway," suggesting investors were willing to overlook the backward-looking numbers in favor of forward guidance. The earnings call transcript mentions SpoiledChild momentum as an offset and management's outlook for sequential improvement in H2 2026. This pattern—depressed current-quarter results offset by credible new product momentum and improving forward guidance—is a common catalyst for positive equity reactions. Investors appear to have focused on the turnaround narrative (new ventures gaining traction) rather than the absolute revenue miss, a shift in sentiment that would justify a 14.64% one-day gain.

LBGJ

LBGJIndustrials

$2.25+$0.29

+14.6%

NASDAQ · Mkt cap $58 K

No headlines were found in the last 48 hours explaining the 14.56% gain, so the cause remains unclear without additional context or news sources.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for LBGJ's 14.56% single-day gain. This kind of move in a lower-priced NASDAQ stock could stem from several common drivers: a delayed news release not yet picked up by Yahoo Finance RSS, short covering or technical buying following a breakdown level, sector rotation tailwinds, a corporate announcement made outside typical news cycles, or pure intraday momentum and retail interest. Without access to SEC filings, company press releases, or real-time data feeds beyond the provided headlines, attributing this move to any particular event would be speculation. The timing on September 11 offers no obvious macro catalyst context either.

DMIIR

Drugs Made In America Acquisition II Corp. Right

$0.08+$0.01

+14.4%

NASDAQ

No relevant news found in the last 48 hours; the 14.45% gain in a SPAC rights unit is most likely driven by technical or sentiment factors rather than a confirmed corporate announcement.

DMIIR is a SPAC rights unit, a security class prone to volatile micro-cap trading with limited liquidity. The absence of any headlines in the past two days means no identifiable news catalyst such as a merger announcement, deal update, or business development has been reported. The stock's low price of $0.08 and status as the 49 gainer suggest the move could reflect short-covering, retail interest, broader sentiment toward blank-check vehicles, or simply illiquid order flow creating outsized percentage moves. Rights units in particular can experience sharp swings on minimal volume because position sizes are small and the shareholder base is typically thin. Without headlines or confirmed structural catalysts, attribution to any specific event would be speculation.

AUID

Ipsidy Inc.Technology

$0.41+$0.05

+14.0%

NASDAQ · Mkt cap $7.0 M

No news headlines were available in the last 48 hours, so the 13.95% gain cannot be directly attributed to a confirmed announcement or earnings surprise. The move likely reflects technical buying, short covering, or delayed market reaction to an untracked event.

Ipsidy Inc. is a small-cap cybersecurity and identity verification company trading at $0.41, and the absence of recent news headlines makes direct causation impossible to establish from the provided sources. For microcap stocks in this price range, significant single-day moves often occur from several possible catalysts not captured by mainstream financial news feeds: technical chart breaks, short squeezes due to low float and high short interest, insider buying or dilution announcements on company websites or SEC filings not yet syndicated to Yahoo Finance, penny stock promotion or social media discussion, or delayed market digestion of older press releases. Without access to SEC filings, company press releases, or intraday volume data, we cannot pinpoint which mechanism drove today's move. The rank as the 50th biggest gainer suggests broad market participation, which slightly favors technical or sentiment-driven moves over a single micro-event.

Biggest Losers

Fri, Sep 11, 2026 50

BPTH

Bio-Path Holdings Inc

$0.00−$0.03

-99.7%

WTER

Alkaline Water Co Inc-TheConsumer Defensive

$0.02−$0.02

-44.3%

NASDAQ · Mkt cap $1.1 M

No news headlines were reported in the last 48 hours, so the 44% intraday drop cannot be attributed to a specific public announcement. The move likely reflects either a technical breakdown, delayed negative news, or a liquidity event in a micro-cap stock.

The Alkaline Water Company is a micro-cap beverage stock trading at $0.02, where price swings can be extreme due to minimal liquidity and high volatility. With zero headlines in the last 48 hours, the catalyst is not immediately identifiable from public news sources. For stocks at this price and market cap, losses of this magnitude typically stem from one of three categories: first, a delayed announcement or filing (SEC report, financing, covenant breach) that has not yet surfaced in mainstream news aggregation; second, a technical or forced liquidation event (margin call, short squeeze reversal, or fund redemption); or third, deteriorating fundamentals or rumors circulating in over-the-counter market channels not captured by major news feeds. Alkaline water beverage companies have faced persistent margin pressure and consumption headwinds, so fundamental concerns cannot be ruled out.

VACI.UN

Viking Acquisition Corp. I

$6.50−$3.40

-34.3%

UCAR

U Power Limited - Ordinary SharesConsumer Cyclical

$4.97−$2.43

-32.8%

NASDAQ · Mkt cap $15 M

No news headlines were found in the last 48 hours to explain UCAR's sharp 32.84% decline, making the specific trigger unknown without additional reporting.

The absence of any recent news headlines in the provided data means we cannot identify a concrete catalyst for this significant single-day drop. U Power Limited is a smaller-cap NASDAQ-listed company, and moves of this magnitude typically stem from one of several categories: delayed disclosure of company-specific developments (missed earnings, guidance cuts, insider selling, regulatory issues), broad sector weakness in power or utilities, technical selling or forced liquidations, or unconfirmed rumors circulating on social media or alternative news channels. Without access to earnings calendars, SEC filings, or analyst downgrades released during market hours, we cannot determine which mechanism drove this decline. The lack of reporting lag suggests either a very recent announcement that hasn't yet been picked up by major feeds, or a market reaction to something outside traditional news channels.

OPTT

Ocean Power Technologies IncIndustrials

$0.11−$0.05

-32.4%

NYSE · Mkt cap $52 M

Ocean Power Technologies announced a 1-for-30 reverse stock split effective September 14, which typically signals financial distress and dilution concerns, triggering a sharp 32% pre-split decline as investors exit ahead of the adjustment.

The company announced a reverse stock split on September 10-11, a corporate action that typically reflects an attempt to raise the nominal per-share price and maintain compliance with exchange listing standards. Reverse splits are generally viewed negatively by the market because they signal a company in financial difficulty and do not create economic value—each shareholder's ownership percentage remains unchanged post-split. The timing of the 32% decline on the announcement date is consistent with investor reallocation and capitulation selling ahead of the split-adjusted opening on September 14. The positive news about the U.S. Army maritime drone demonstration appears insufficient to offset the negative signal from the reverse split announcement. This is a structural event in a micro-cap stock with likely limited analyst coverage and weak liquidity, making it vulnerable to sharp sentiment swings.

SVVC

Firsthand Technology Value Fund IncFinancial Services

$0.01−$0.00

-30.0%

NASDAQ · Mkt cap $49 K

No news headlines were available in the last 48 hours to explain SVVC's 30% single-day drop to $0.01, making the precise trigger unknown, though this stock category typically falls on asset valuation declines or liquidity events.

Firsthand Technology Value Fund Inc is a closed-end fund holding venture and private equity stakes, a category prone to sharp moves on net asset value shifts, portfolio company news, or broader venture market sentiment swings. The absence of any news in the last 48 hours is notable but not disqualifying; the catalyst could be external (venture funding slowdown, tech sector weakness) or internal (a major portfolio holding announcement, fund-level disclosure, or delisting pressure as the stock has fallen to penny-stock levels). At $0.01 with a 30% single-day loss, the stock is in deep distress territory, which often reflects cumulative fundamental deterioration rather than a single event. The lack of available headlines suggests either the move preceded major news coverage or was driven by technical factors and institutional redemptions rather than a named corporate action.

CDT

Conduit Pharmaceuticals IncHealthcare

$0.25−$0.10

-28.4%

BEAGR

Bold Eagle Acquisition Corp. Right

$0.18−$0.07

-28.0%

NASDAQ

No news headlines were found in the last 48 hours to explain the 28% decline in BEAGR, a SPAC rights offering. The drop likely reflects typical illiquidity and volatility in this security class or a delayed market reaction to an earlier event.

Bold Eagle Acquisition Corp. Right is a SPAC-related security (the "Right" designation indicates a separate warrant or rights offering). These instruments are inherently volatile and thinly traded. Without any news catalyst reported in the last 48 hours, the 28% one-day decline could reflect several plausible but unconfirmed causes: rotation out of SPAC-related positions, a delayed market reaction to a merger announcement or regulatory filing from days prior, broad redemption activity in the SPAC, or simple illiquidity on a down move triggering stop-losses. Rights and warrants in particular are prone to sharp swings on low volume. Without access to intraday order flow, filing dates, or institutional activity, determining the precise trigger is not possible from available evidence.

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.06−$0.02

-26.7%

NASDAQ · Mkt cap $5.5 M

No news headlines were available in the last 48 hours, so the 26.67% drop cannot be directly attributed to a specific announced event. The decline likely reflects broader biotech sector weakness, a negative clinical or regulatory development not yet captured in major news feeds, or routine volati…

Hepion Pharmaceuticals is a small-cap biopharmaceutical company with typically low trading volume and liquidity, characteristics that often result in significant price swings on modest trading activity or sentiment shifts. Without any recent news headlines to anchor the move, several categories of catalyst are plausible. First, a negative clinical trial result, regulatory setback, or patent issue may have been disclosed through an SEC filing or press release not yet aggregated by Yahoo Finance RSS. Second, broader biotech sector weakness or a decline in investor risk appetite could mechanically pressure a speculative microcap. Third, the stock may have experienced a technical or momentum-driven reversal unconnected to fundamentals. Given the stock's trading at $0.06, micro-cap volatility amplifies small absolute moves into large percentage changes, and liquidity constraints can exaggerate intraday swings.

OLMA

Olema Pharmaceuticals IncHealthcare

$10.23−$2.71

-25.9%

NASDAQ · Mkt cap $939 M

No news headlines were found in the last 48 hours, so the 25.86% decline cannot be attributed to a specific disclosed event; the drop likely reflects either a delayed market reaction to older news, a clinical or regulatory setback, or sector-wide pressure on biotech stocks.

Olema Pharmaceuticals is a clinical-stage biopharmaceutical company, and its stock experienced a sharp single-day loss of over 25% with no recent news available to explain it. This disconnect suggests either a significant event occurred that has not yet been picked up by major news feeds, or the market is reacting to information released more than 48 hours ago. For biotech firms at Olema's stage, typical catalysts include clinical trial results, regulatory decisions (FDA feedback letters or approvals), partnership announcements, or guidance changes. The magnitude of the decline and its ranking as the tenth-biggest loser of the day indicates this was a material, market-wide event rather than isolated trading noise. Without headline evidence, the most probable categories are a clinical setback in an ongoing trial or a negative regulatory development that was announced earlier and is only now being fully digested by the market.

CVV

CVD Equipment CorpIndustrials

$4.75−$1.56

-24.7%

NASDAQ · Mkt cap $56 M

CVD Equipment announced a major restructuring plan and leadership transition on September 10, accompanied by workforce reduction of approximately 50%, triggering a -24.66% stock decline on September 11.

The company disclosed a restructuring plan and leadership transition following what the filing describes as a thorough evaluation of strategic alternatives. The second headline fragment indicates the president and chief executive are part of this announcement, though the full details of the leadership change are truncated in the RSS feed. A 50% workforce reduction is a material negative signal to investors, typically suggesting operational challenges, diminished growth prospects, or financial distress requiring cost containment. Such announcements commonly trigger sharp single-day selloffs as investors reassess the company's trajectory and near-term profitability. The timing suggests the market reacted directly to the September 10 announcement on the following trading day.

ADBT

Advasa Holdings, Inc.

$0.23−$0.07

-24.4%

TONT.WT

Graf Global Corp.

$0.37−$0.11

-23.2%

RBOT

D8 Holdings Corp.Healthcare

$0.03−$0.01

-22.9%

NYSE · Mkt cap $257 K

No news headlines were found in the last 48 hours, so the 22.88% decline cannot be attributed to a specific announced event. The drop likely reflects technical selling, low liquidity, or delayed market reaction to undisclosed developments.

The absence of any news in the Yahoo Finance RSS feed over the past two days means no public catalyst can be directly confirmed. RBOT is trading at $0.03, indicating an extremely low-priced, likely micro-cap or distressed security. Stocks at this price level are prone to sharp moves on minimal volume, technical breakdown, forced liquidations, or short-covering reversals. Without access to insider activity, regulatory filings, or market-depth data, it is impossible to determine whether this decline was driven by fundamental deterioration, a rumor or tweet, algorithmic selling, or simple mean-reversion on very thin floats. The lack of news coverage itself may suggest the stock lacks analyst attention or that any catalyst occurred outside official channels.

LHSW

Lianhe Sowell International Group Ltd Ordinary SharesTechnology

$0.48−$0.14

-22.6%

NASDAQ · Mkt cap $9.6 M

No news headlines were found in the last 48 hours, so the 22.58% decline cannot be attributed to a specific announced catalyst. The drop likely reflects technical selling, market-wide pressure, or unannounced company developments.

The absence of recent news makes it impossible to pinpoint a concrete cause for this sharp decline. LHSW is a thinly-traded microcap on NASDAQ, and such securities are prone to significant price swings driven by technical factors, low-volume selling, or sentiment shifts that may not generate immediate media coverage. Possible categories include: first, a delayed disclosure or insider filing that has not yet been indexed by major news feeds; second, sector-wide pressure affecting Chinese equities or the broader market; third, technical breakdown after previous resistance levels, common in low-liquidity stocks. Without substantive information about the company's operations, recent filings, or market conditions, attribution remains speculative.

AHMA

Ambitions Enterprise Management Co. L.L.CConsumer Cyclical

$1.48−$0.39

-21.6%

NASDAQ · Mkt cap $46 M

No news headlines were found in the last 48 hours for AHMA, so the 21.61% drop cannot be attributed to a specific announced event; the cause remains unknown without access to broader market data or intraday developments.

The absence of recent news headlines in this timeframe means we cannot identify a company-specific catalyst for the sharp decline. AHMA is a low-priced NASDAQ stock, which can be susceptible to technical selling, liquidity events, or sector-wide pressure that may not generate immediate headline coverage. Possible categories of cause include technical support breakdowns in a thinly traded security, delayed disclosure of earnings or guidance, a broader market selloff affecting small-cap or micro-cap stocks, short-covering reversals, or rumors circulating on social media or forums without formal news coverage. Without additional reporting or structural knowledge of the company, the exact trigger cannot be determined from the evidence at hand.

COLAR

Columbus Acquisition Corp Rights

$0.40−$0.11

-20.8%

SGLY

Singularity Future Technology Ltd.Industrials

$1.57−$0.40

-20.6%

NASDAQ · Mkt cap $2.7 M

No news headlines were found in the last 48 hours, so the 20.62% drop cannot be attributed to a specific announced event. The decline likely reflects broader market sentiment, technical selling, or unannounced company developments.

The absence of recent news makes it difficult to pinpoint a direct catalyst for the sharp 20.62% decline in SGLY. Singularity Future Technology is a micro-cap NASDAQ-listed company, and stocks in this category often experience outsized moves on limited volume driven by sentiment shifts, short-term technical breakdowns, or delayed disclosure of material events that may not immediately appear in major news feeds. Without headlines, the move could reflect accumulating negative sentiment about the company's fundamentals, sector rotation away from speculative tech plays, or a delayed market reaction to news that has not yet reached primary financial news channels. Alternatively, this could be a technical break or a response to pre-market rumors not yet formalized in official disclosures.

GCTK

GlucoTrack, Inc.Healthcare

$2.56−$0.66

-20.5%

NASDAQ · Mkt cap $3.7 M

GlucoTrack announced an $11.5M convertible note financing on the same day the stock fell 20.5%, likely signaling shareholder dilution concerns and possible weak capital position that investors view negatively despite the company's framing as strategic growth support.

The timing of the financing announcement and the sharp decline on the same day suggest investor concern about dilution and the underlying reason for the capital raise. Convertible notes are inherently dilutive to existing shareholders and often signal that a company faces cash constraints or needs capital quickly to fund operations or strategic initiatives. While the headline frames this as supporting growth, the market's interpretation appears to be more pessimistic. The stock's ranking as the 19th biggest loser suggests this was a broad-based sell-off in GCTK rather than a narrow technical move. Without additional context on the company's cash burn, competitive position, or prior guidance, we cannot determine whether this financing represents a healthy strategic move or a warning sign about financial stability. The degree of the drop exceeds typical dilution reactions, suggesting investors may be reading additional negative signals into the announcement or the market has existing concerns about the company's prospects.

ADIL

Adial Pharmaceuticals IncHealthcare

$4.93−$1.24

-20.1%

NASDAQ · Mkt cap $15 M

No news headlines were found in the last 48 hours, so the 20.14% drop cannot be directly attributed to a disclosed event; the decline may reflect investor reallocation, sector weakness, or undisclosed company developments.

The absence of any news headlines in the RSS feed over the past 48 hours means the cause of ADIL's sharp 20.14% decline cannot be pinned to a specific disclosed catalyst such as earnings, FDA action, financing developments, or guidance changes. For a smaller pharmaceutical company like Adial, price drops of this magnitude typically correlate with clinical trial failures, capital structure concerns, insider selling, short-seller activity, or broader biotech sector weakness. Without headline confirmation, we cannot determine which of these—if any—drove today's move. The stock's ranking as the 20th biggest loser suggests the decline was part of a broader market pattern rather than isolated volatility, which could indicate sector rotation or deteriorating risk sentiment toward smaller-cap pharma names.

GWAV

Greenwave Technology Solutions, Inc.Industrials

$3.78−$0.87

-18.7%

NASDAQ · Mkt cap $2.9 M

GWAV dropped 18.71% on September 11, 2026, but no news headlines are available from the past 48 hours to explain the move, so the cause remains unclear.

The absence of recent news headlines is notable given the magnitude of the decline. GWAV is ranked as the 21st biggest loser of the day, indicating a significant sell-off. For a company of this type (small-cap technology), such sharp moves can be triggered by several categories of events: unannounced earnings misses or guidance reductions, insider selling or secondary offerings, deteriorating market conditions in its sector, delayed disclosure of regulatory issues or contract losses, or broader market deleveraging affecting small-cap stocks. The lack of contemporaneous public news reporting does not rule out material private information reaching select investors or algorithmic trading cascades. Without access to pre-market announcements, Form 4 filings, or verified rumor sources, the specific catalyst cannot be determined from available data.

BENF

BeneficientFinancial Services

$1.08−$0.23

-18.0%

NASDAQ · Mkt cap $33 M

No news headlines were available in the last 48 hours for BENF, so the 17.97% single-day drop likely stems from a delayed announcement, technical breakdown, sector-wide pressure, or undisclosed catalyst not yet surfaced in public feeds.

The absence of any news headlines in the provided feeds over the past two days makes it impossible to identify a specific event that triggered the sharp decline. BENF is a micro-cap specialty finance company, and such stocks are prone to volatility driven by several factors not always captured immediately in major news aggregators: delayed regulatory filings or compliance issues, insider selling or lock-up expirations, shifts in lending conditions or credit markets affecting alternative asset financing, short-covering reversals after prior rallies, or simple liquidity evaporation on low volume. Without a named catalyst, the most honest assessment is that the move lacks explanation in the available evidence, though the stock's illiquidity profile and niche market positioning make it susceptible to both information gaps and momentum-driven swings.

GRML

Greenland Mines Ltd.Basic Materials

$3.15−$0.68

-17.7%

NASDAQ · Mkt cap $31 M

Greenland Mines fell 17.67% despite announcing operational progress on two mineral projects; the drop likely reflects market disappointment that the acquisitions and field work have not yet translated into near-term value creation or updated resource estimates.

The two headlines released in the past 48 hours are operationally positive: the company completed a bulk-sampling program at Skaergaard and finalized its acquisition of Neo North Star Resources to diversify from a single-asset bet. However, neither headline contains financial guidance, updated mineral resource estimates, timeline acceleration, or third-party validation that would typically drive a stock higher on acquisition completion. For a small-cap mining exploration company, investors often discount early-stage drilling and bulk-sampling announcements unless they are accompanied by dramatic grade improvements or significant reserve upgrades. The 17.67% single-day drop suggests the market either expected more substantive news (e.g., assay results or an upgraded feasibility study), interprets the diversification move as a sign management has lost confidence in Skaergaard's standalone potential, or is simply taking profits after prior strength. Without dissenting analyst notes or insider selling data, the precise driver remains partly inference rather than fact.

ZVZZT

$25.03−$5.03

-16.7%

NSAIR

NorthStrive Acquisition Corp I. Rights

$0.14−$0.03

-16.7%

SKYH.WT

Sky Harbour Group Corporation

$0.18−$0.04

-16.6%

PMTS

CPI Card Group Inc

$22.47−$4.36

-16.3%

HUBC

Hub Cyber Security Ltd. - Ordinary SharesTechnology

$0.34−$0.07

-16.1%

NASDAQ · Mkt cap $23 M

Hub Cyber Security announced a reverse share split on September 10, which typically signals financial distress or delisting risk and triggered a 16% single-day sell-off as investors reacted to the dilution mechanics and underlying concerns such an action implies.

The company announced a reverse share split, a corporate action commonly undertaken to restore compliance with minimum share price requirements or improve the appearance of financial health. While the headline provided does not specify the exact terms, the timing of the announcement on September 10 and the sharp 16% decline on September 11 strongly suggests investor concern about what the reverse split signals: potential Nasdaq listing rule violations, shareholder dilution concerns, or broader financial stress. Reverse splits are frequently perceived negatively by the market because they do not create real economic value and often precede further negative developments. The stock's position as the 28th biggest loser suggests this was a material repricing event tied directly to the corporate action announcement.

SLXN

Biomotion SciencesHealthcare

$0.35−$0.07

-16.0%

NASDAQ · Mkt cap $540 K

No news headlines were found in the last 48 hours, so the 16% drop in SLXN cannot be attributed to a specific reported event; the decline likely stems from technical selling, market-wide pressure, or an untracked announcement or rumor.

The absence of any news in the Yahoo Finance RSS feed in the last 48 hours makes it impossible to link this substantial 16% decline to a concrete catalyst. For a micro-cap biotech stock trading at $0.35, declines of this magnitude are often driven by sector-wide weakness in small-cap life sciences, technical momentum reversals, short covering, or insider activity that may not immediately surface in major news feeds. Biomotion Sciences, as a small-cap medical device or therapeutics company, could also be responding to delayed regulatory updates, clinical trial results posted on investor portals, or analyst downgrades that haven't yet propagated to headline services. Without reported news, the move remains mechanically unexplained.

SDST

Stardust Power Inc.Industrials

$0.14−$0.03

-15.9%

NASDAQ · Mkt cap $8.6 M

No headlines were published in the last 48 hours for Stardust Power Inc., so the 15.93% drop cannot be attributed to a specific news event based on available evidence. The decline likely stems from technical selling, sector weakness, or undisclosed developments.

The absence of any Yahoo Finance headlines in the 48-hour window preceding the 15.93% decline means we cannot ground the move in a specific corporate announcement, earnings report, regulatory action, or other discrete event. For a stock trading at $0.14, typical catalysts include liquidity concerns, dilution from secondary offerings, deterioration in cash position, missed milestones in development-stage companies, or shifts in market sentiment toward the clean energy or power sector more broadly. Penny stocks and micro-cap equities are also more susceptible to algorithmic selling, momentum reversals, or changes in short interest. Without headlines, we must acknowledge this is speculative.

TLS

Telos CorpTechnology

$3.94−$0.74

-15.7%

NASDAQ · Mkt cap $331 M

Wedbush downgraded Telos as part of a cybersecurity sector reshuffling that elevated CrowdStrike and Palo Alto Networks as AI winners, causing the 15.72% drop on September 11.

On September 11, Wedbush released research naming CrowdStrike and Palo Alto Networks as emerging winners in the AI-driven cybersecurity market transformation. In the same research window, Telos was explicitly downgraded by the same analyst. This is a direct negative catalyst: a major sell-side firm has signaled reduced conviction in Telos relative to larger, better-positioned competitors in the AI cybersecurity space. The timing of the downgrade announcement aligns precisely with the intraday move, and the sector rotation theme—away from smaller-cap names like Telos toward mega-cap leaders—is consistent with institutional reallocation. This represents a clear relative underperformance call rather than company-specific bad news.

SMR

NuScale Power Corporation

$8.61−$1.60

-15.6%

BIAF

bioAffinity Technologies, Inc. Healthcare

$7.93−$1.45

-15.5%

NASDAQ · Mkt cap $3.3 M

No news headlines were available in the last 48 hours to explain BIAF's 15.47% single-day drop, so the cause remains unclear from public sources.

bioAffinity Technologies is a small-cap diagnostic company trading on NASDAQ, and the absence of any headlines in the last 48 hours suggests the sell-off was not driven by a major announced event, earnings release, or regulatory action that would typically be reported. For a stock of this size and sector, sharp intraday moves can result from several sources: technical selling following a prior run-up or breakdown of a key price level, sector-wide pressure in diagnostics or healthcare, low-volume cascading stop-losses, delayed news from before the 48-hour window, or unconfirmed rumors on social media or message boards. Without visibility into volume, short interest, or prior price action, we cannot determine whether this is a correction, capitulation, or noise typical of lower-liquidity names.

UFG

Uni-Fuels Holdings LimitedIndustrials

$0.56−$0.10

-14.9%

NASDAQ · Mkt cap $19 M

No news headlines were published in the last 48 hours about UFG, so the 14.86% drop cannot be attributed to any specific corporate announcement or public event identified in available sources.

The absence of recent news makes it impossible to pinpoint a concrete cause for the decline. UFG (Uni-Fuels Holdings Limited) experienced a substantial one-day loss, ranking as the 34th biggest loser on NASDAQ, yet no material announcements appear in the headline feed covering the past two days. The stock could have declined due to several plausible but unconfirmed mechanisms: a delayed announcement or regulatory filing not yet picked up by news aggregators, a broader market or sector rotation, technical selling or stop-loss triggers, changes in analyst sentiment, insider activity, or reaction to an earnings release or guidance revision issued outside the monitored news window. For a small-cap or microcap stock like this trading at $0.56, liquidity constraints and order imbalances can also amplify moves.

Scienjoy Holding CorporationCommunication Services

$0.70−$0.12

-14.6%

NASDAQ · Mkt cap $40 M

No news headlines were available in the last 48 hours to explain SJ's 14.61% decline, so the driver remains unclear without additional context or intraday catalysts.

Scienjoy Holding Corporation dropped nearly 15% on September 11, 2026, but the Yahoo Finance RSS feed returned no headlines in the preceding 48 hours that would account for the move. This absence of attributable news leaves the catalyst uncertain. For a micro-cap or thinly traded stock like SJ, typical drivers of such declines without obvious announcements include technical selling following previous rallies, delayed negative earnings or guidance releases not yet captured in the news feed, broader sector rotation, or execution of insider selling. Without visibility into company-specific announcements, trading volume, or institutional activity on the date itself, it is impossible to pinpoint the cause with confidence. The stock's low price point and NASDAQ listing suggest it may be subject to higher volatility and lower institutional coverage, which could amplify moves on thin or rumor-driven trading.

IRHOR

Iron Horse Acquisitions Corp. II Rights

$0.16−$0.03

-14.5%

NASDAQ

No news headlines were found in the last 48 hours, so the 14.53% drop likely stems from typical factors affecting SPAC rights securities such as redemption pressure, market-wide volatility, or shifts in the underlying merger prospects.

Iron Horse Acquisitions Corp. II Rights is a SPAC rights instrument, a security class particularly sensitive to investor sentiment around the underlying blank-check company's merger timeline and terms. The absence of any news in the past 48 hours suggests the decline was not triggered by a specific announced event. SPAC rights holders face structural pressures including time decay, redemption dynamics when common shareholders exit, and uncertainty about whether a merger will occur before the deadline. Rights lose value if the sponsor fails to complete a deal or if redemptions erode the trust's capital base. The sharp single-day drop could reflect broader redemption activity, negative sentiment about current SPAC merger targets in the market, or technical selling in a thinly traded security. Without access to the current status of Iron Horse's merger efforts or aggregate redemption data, the most likely explanation falls into general SPAC structural risk rather than company-specific news.

SLS

SELLAS Life Sciences Group IncHealthcare

$11.55−$1.94

-14.4%

NASDAQ · Mkt cap $2.8 B

SLS dropped 14.39% on September 11 with no direct negative catalyst in the provided headlines; the only news mentions a Manulife subsidiary increasing its stake in another company (IBRX), which does not directly explain SLS's decline.

The headline provided discusses Manulife Financial's unit raising its position in IBRX ahead of key cancer-related catalysts, but this news appears unrelated to SELLAS Life Sciences (SLS) itself. The article may have been included in a broader cancer biotech sector wrap or portfolio context, but it does not contain any specific announcement about SLS's pipeline, clinical trials, partnerships, or financial performance. Biotech stocks of this size and stage (development-stage immunotherapy companies) are typically sensitive to clinical trial results, regulatory decisions, financing announcements, and sector sentiment shifts. Without a headline directly tied to SLS, the decline could reflect disappointing interim data release, a delayed catalyst, sector rotation out of earlier-stage oncology names, or broader market technicals, but the evidence provided does not pinpoint the cause.

PAII.WT

Pyrophyte Acquisition Corp. II WT

$0.31−$0.05

-13.9%

IPDN

Professional Diversity Network IncIndustrials

$0.12−$0.02

-13.5%

NASDAQ · Mkt cap $2.7 M

No news headlines were found in the last 48 hours to explain the 13.54% drop in IPDN, making the specific catalyst unclear without additional reporting or company announcements.

The absence of any recent news headlines in the Yahoo Finance RSS feed means the stated cause of the decline cannot be directly attributed to a specific company announcement, earnings report, regulatory action, or market event that was publicly disclosed in the past two days. For a micro-cap stock trading at $0.12, typical catalysts for sharp single-day declines include dilutive secondary offerings, insider selling, short-seller reports, delayed or negative earnings surprises, failed partnership announcements, or broader market liquidity events affecting penny stocks. Without concrete reporting, it is reasonable to infer that the move may reflect either an unreported development (such as an after-hours filing or social media disclosure), technical selling in a thinly traded security, or a delayed market reaction to an earlier announcement not captured in this snapshot's news feed.

SBXD.WT

SilverBox Corp IV WT

$0.12−$0.02

-13.5%

Equillium IncHealthcare

$2.11−$0.32

-13.0%

NASDAQ · Mkt cap $149 M

No news headlines were found in the last 48 hours for EQ, so the 13% intraday decline likely reflects either a delayed market reaction to an earlier event, a sector-wide downturn, or trading momentum unrelated to disclosed corporate news.

Equillium is a clinical-stage immunology company whose stock moves are typically driven by clinical trial results, FDA feedback, financing announcements, or cash runway concerns. Without recent news coverage, the decline could stem from several sources: a delayed market reaction to a press release issued just outside the 48-hour window, broad biotech sector weakness, options expiration dynamics, short-term technical selling, or accumulating concerns about cash burn that haven't yet triggered a formal announcement. For small-cap biotech stocks trading below $3, liquidity and sentiment can shift sharply on low volume without accompanying headlines. Without access to earnings calendars, trial timelines, or intraday company announcements, identifying the specific catalyst is speculative.

RENT

Rent the Runway, Inc.

$2.45−$0.37

-13.0%

AXR

AMREP Corp

$22.93−$2.96

-12.9%

NOMA

NOMADAR Corp.Consumer Cyclical

$1.48−$0.22

-12.7%

NASDAQ · Mkt cap $38 M

No news headlines were published about NOMA in the last 48 hours, so the 12.72% drop cannot be attributed to a specific company announcement or market event based on available information.

The absence of recent news makes it impossible to pinpoint a definitive catalyst for NOMA's sharp decline. A 12.72% single-day drop for a stock trading near $1.50 could reflect several categories of event: a delayed earnings report or guidance miss that circulated offline, a sector-wide selloff affecting small-cap technology or biotech names, short-covering or speculative position unwinding, or technical selling pressure following a prior run. Micro-cap and penny stocks are particularly susceptible to volatility driven by low liquidity, insider trades, or unindexed news that fails to reach major financial RSS feeds. Without headlines or official company filings, the true driver remains opaque.

IMSR

Terrestrial Energy Inc.

$4.75−$0.68

-12.5%

ZUMZ

Zumiez IncConsumer Cyclical

$14.57−$2.09

-12.5%

NASDAQ · Mkt cap $304 M

Zumiez reported Q2 earnings and revenue that missed analyst expectations, posted a wider net loss, and cut Q3 guidance lower, triggering a 12.5% stock decline as the market repriced the retailer's growth outlook downward.

On September 10-11, 2026, Zumiez reported fiscal Q2 results that fell short on multiple fronts. Revenue of $209 million declined 2.5% year-over-year and missed consensus expectations by 1.49%. The company posted a wider net loss and missed earnings estimates by 21.43%. Most critically, management issued Q3 2026 guidance of $224 million, which fell below analyst expectations. The primary weakness cited was U.S. footwear softness and declining North America transaction traffic, which outweighed positive international comparable-sales growth. The combination of a miss on current results, negative earnings surprise, and a cut to forward guidance typically triggers sharp repricing in retail stocks, as it signals deteriorating near-term demand and erodes investor confidence in management's ability to stabilize the business.

GELS

Gelteq Limited Ordinary SharesHealthcare

$0.70−$0.10

-12.5%

NASDAQ · Mkt cap $6.0 M

GELS fell 12.49% on September 11, 2026, with no news headlines appearing in the prior 48 hours, making the specific catalyst unclear and likely driven by technical, sentiment, or undisclosed company developments.

No recent headlines were found in the Yahoo Finance RSS feed for the past two days, so the immediate cause of the 12.49% decline cannot be directly attributed to a named news event such as earnings, regulatory action, or strategic announcement. For a microcap or thinly traded security like GELS trading at $0.70, price movements of this magnitude are not uncommon and can stem from several sources: broad market sell-offs affecting risk assets, sector rotation, accumulation of negative sentiment from delayed earnings or guidance misses announced earlier, insider transactions, or technical breakdown through support levels. Without access to real-time order flow, company filings, or social-media chatter, identifying the specific trigger requires inference only.

MBRX

Moleculin Biotech IncHealthcare

$0.73−$0.10

-12.5%

NASDAQ · Mkt cap $4.3 M

Moleculin announced availability of its H.C. Wainwright Conference presentation on September 11, but the announcement provides no details about content or outcomes, leaving the 12.46% intraday drop unexplained by the headline itself.

The only headline available is a procedural announcement that Moleculin's pre-recorded presentation from the H.C. Wainwright Conference is now available on-demand. The headline is truncated and contains no information about presentation content, clinical trial results, financial metrics, pipeline updates, or any other material developments that would typically trigger a significant stock decline. For a small-cap biotech company like Moleculin, the most common drivers of sharp single-day losses are clinical trial setbacks or negative data releases, disappointing pipeline announcements, cash burn concerns, dilutive financing events, or negative analyst commentary. Without access to the actual presentation content or other news from the past 48 hours, the cause of this decline cannot be definitively attributed to the conference announcement itself, which appears to be merely notification that recorded remarks are accessible.

RYET

RUANYUN EDAI TECHNOLOGY INCConsumer Defensive

$0.72−$0.10

-12.4%

NASDAQ · Mkt cap $39 M

RYET dropped 12.42% on September 11, likely due to broader market disappointment or profit-taking following the previous day's MOU announcement with Changan Anyi and Intersect regarding a Saudi NEV education institute, which may have failed to sustain investor enthusiasm.

On September 10, RYET announced a memorandum of understanding with Changan Anyi and Intersect to establish a Saudi National Electric Vehicle Institute, framed as advancing the company's international education strategy. This appears to be a partnership or expansion announcement rather than a major revenue-generating contract. The stock sold off sharply the following day, suggesting the market either viewed the MOU as insufficient to justify current valuation, lacked confidence in its near-term monetization, or simply used the announcement as a trigger for profit-taking after any pre-announcement rally. Alternatively, the decline could reflect broader sector weakness, deteriorating sentiment toward Chinese tech firms, or unrelated technical selling pressure. Without visibility into institutional positioning or concurrent market conditions on September 11, the exact mechanism remains inferential.

MGN

Megan Holdings LimitedIndustrials

$0.17−$0.02

-12.3%

NASDAQ · Mkt cap $3.7 M

MGN fell 12.34% on September 11, 2026, but no news headlines from the past 48 hours are available to identify a specific catalyst, making the cause unclear without additional reporting.

The absence of recent headlines in this data snapshot means we cannot pinpoint a concrete reason for the decline. MGN is trading at a very low price ($0.17), which often characterizes penny stocks or severely distressed companies vulnerable to technical selling, short-covering reversals, broader market selloffs, or untracked news from sources outside major financial wire services. Micro-cap stocks in this price range frequently experience sharp single-day moves on minimal volume or driven by factors not widely covered by mainstream financial media. Without access to company filings, social media activity, or alternative news sources, identifying the specific trigger is not possible from the information provided.